Bullfrog AI Holdings, Inc. Common Stock (BFRG) 10-Year Financial Performance & Capital Metrics

BFRG • • Industrial / General

HealthcareHealthcare ITHealthcare Data Analytics & AIAI-Powered Clinical Analytics

AboutBullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.Show more

Revenue $0 -100.0%
EBITDA -$7M -34.8%
Net Income -$7M -30.6%
EPS (Diluted) -0.85 +4.5%
Gross Margin -
EBITDA Margin -
Operating Margin -
Net Margin -
ROE -185.12% +10.4%
ROIC -
Debt/Equity -
Interest Coverage -398.52 -487.2%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading at only 1.3x book value

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Weak momentum: RS Rating 6 (bottom 6%)
✗Shares diluted 36.3% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-2.38%

EPS CAGR

10Y-

5Y-

3Y-

TTM19.1%

ROCE

10Y Avg-199.3%

5Y Avg-199.3%

3Y Avg-199.3%

Latest-191.54%

Peer Comparison

AI-Powered Clinical Analytics

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
FOXOFOXO Technologies Inc.	175.02K	0.00	-0.00	26.89%	-66.46%	-48.71%	2.70
HCTIHealthcare Triangle, Inc.	3.27M	0.45	-0.00	-64.77%	-48.85%	-72.45%
BFRGWBullfrog AI Holdings, Inc. Warrants	2.05M	0.20	-0.23	-100%	-57.71%	-346.39%
BFRGBullfrog AI Holdings, Inc. Common Stock	8.66M	0.76	-0.89	-100%	-57.71%	-346.39%

Profit & Loss

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	10K	65K	0
Revenue Growth %	-	-	-	5.5%	-1%
Cost of Goods Sold+	0	0	800	5.2K	0
COGS % of Revenue	-	-	0.08%	0.08%	-
Gross Profit+	0	0	9.2K	59.8K	0
Gross Margin %	-	-	0.92%	0.92%	-
Gross Profit Growth %	-	-	-	5.5%	-1%
Operating Expenses+	347.19K	555.36K	2.46M	5.43M	7.24M
OpEx % of Revenue	-	-	246.5%	83.5%	-
Selling, General & Admin	347.19K	530.36K	1.86M	3.99M	5.01M
SG&A % of Revenue	-	-	185.57%	61.46%	-
Research & Development	0	25K	609.27K	1.43M	2.22M
R&D % of Revenue	-	-	60.93%	22.04%	-
Other Operating Expenses	0	0	0	0	0
Operating Income+	-347.19K	-555.36K	-2.46M	-5.37M	-7.24M
Operating Margin %	-	-	-245.58%	-82.58%	-
Operating Income Growth %	-	-0.6%	-3.42%	-1.19%	-0.35%
EBITDA+	-140.9K	-545.45K	-2.45M	-5.37M	-7.23M
EBITDA Margin %	-	-	-245.48%	-82.55%	-
EBITDA Growth %	-	-2.87%	-3.5%	-1.19%	-0.35%
D&A (Non-Cash Add-back)	206.3K	0	1.04K	1.73K	1.72K
EBIT	-329.92K	-545.45K	-2.46M	-5.28M	-6.98M
Net Interest Income+	-11.77K	-40.4K	-346.69K	104.61K	242.74K
Interest Income	0	0	459	183.7K	260.89K
Interest Expense	11.77K	40.4K	347.14K	79.09K	18.16K
Other Income/Expense	5.5K	-30.48K	-346.69K	11.65K	242.74K
Pretax Income+	-341.69K	-585.84K	-2.8M	-5.36M	-6.99M
Pretax Margin %	-	-	-280.25%	-82.4%	-
Income Tax+	0	0	0	0	0
Effective Tax Rate %	1%	1%	1%	1%	1%
Net Income+	-341.69K	-585.84K	-2.8M	-5.36M	-6.99M
Net Margin %	-	-	-280.25%	-82.4%	-
Net Income Growth %	-	-0.71%	-3.78%	-0.91%	-0.31%
Net Income (Continuing)	-341.69K	-585.84K	-2.8M	-5.36M	-6.99M
Discontinued Operations	0	0	0	0	0
Minority Interest	0	0	0	0	0
EPS (Diluted)+	-0.06	-0.10	-0.46	-0.89	-0.85
EPS Growth %	-	-0.65%	-3.6%	-0.93%	0.04%
EPS (Basic)	-0.06	-0.10	-0.46	-0.89	-0.85
Diluted Shares Outstanding	5.65M	5.65M	6.09M	6.05M	8.25M
Basic Shares Outstanding	5.65M	5.65M	6.09M	6.05M	8.25M
Dividend Payout Ratio	-	-	-	-	-

Balance Sheet

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	5.02K	10.01K	72.67K	2.77M	5.55M
Cash & Short-Term Investments	5.02K	10.01K	57.67K	2.62M	5.44M
Cash Only	5.02K	10.01K	57.67K	2.62M	5.44M
Short-Term Investments	0	0	0	0	0
Accounts Receivable	0	0	0	0	0
Days Sales Outstanding	-	-	-	-	-
Inventory	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-
Other Current Assets	0	0	0	0	0
Total Non-Current Assets+	100	0	7.7K	5.97K	4.25K
Property, Plant & Equipment	0	0	7.7K	5.97K	4.25K
Fixed Asset Turnover	-	-	1.30x	10.88x	-
Goodwill	0	0	0	0	0
Intangible Assets	0	0	0	0	0
Long-Term Investments	100	0	0	0	0
Other Non-Current Assets	0	0	0	0	0
Total Assets+	5.02K	10.01K	80.37K	2.78M	5.55M
Asset Turnover	-	-	0.12x	0.02x	-
Asset Growth %	-	1%	7.03%	33.55%	1%
Total Current Liabilities+	545.54K	1.02M	3.14M	184.35K	588.09K
Accounts Payable	94.45K	68.59K	543.99K	103.66K	435.93K
Days Payables Outstanding	-	-	248.2K	7.28K	-
Short-Term Debt	209.92K	586.3K	1.58M	0	0
Deferred Revenue (Current)	0	10K	32K	0	0
Other Current Liabilities	0	0	0	0	0
Current Ratio	0.01x	0.01x	0.02x	15.03x	9.43x
Quick Ratio	0.01x	0.01x	0.02x	15.03x	9.43x
Cash Conversion Cycle	-	-	-	-	-
Total Non-Current Liabilities+	0	0	0	0	0
Long-Term Debt	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0
Deferred Tax Liabilities	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0
Total Liabilities	545.54K	1.02M	3.14M	184.35K	588.09K
Total Debt+	209.92K	586.3K	1.58M	0	0
Net Debt	204.9K	576.29K	1.52M	-2.62M	-5.44M
Debt / Equity	-	-	-	-	-
Debt / EBITDA	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-
Interest Coverage	-29.51x	-13.75x	-7.07x	-67.87x	-398.52x
Total Equity+	-540.52K	-1.01M	-3.06M	2.59M	4.96M
Equity Growth %	-	-0.87%	-2.03%	1.85%	0.91%
Book Value per Share	-0.10	-0.18	-0.50	0.43	0.60
Total Shareholders' Equity	-540.52K	-1.01M	-3.06M	2.59M	4.96M
Common Stock	252	272	40	61	91
Retained Earnings	-1.01M	-1.6M	-4.4M	-9.75M	-16.79M
Treasury Stock	0	0	0	0	0
Accumulated OCI	0	0	0	0	0
Minority Interest	0	0	0	0	0

Cash Flow

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-211.71K	-382.4K	-910.89K	-6M	-5.61M
Operating CF Margin %	-	-	-91.09%	-92.33%	-
Operating CF Growth %	-	-0.81%	-1.38%	-5.59%	0.07%
Net Income	-341.69K	-585.84K	-2.8M	-5.36M	-6.99M
Depreciation & Amortization	0	0	1.04K	1.73K	1.72K
Stock-Based Compensation	87.13K	98.95K	340.15K	631.53K	943.65K
Deferred Taxes	0	0	0	0	0
Other Non-Cash Items	-17.27K	7.29K	413.48K	162.96K	0
Working Capital Changes	60.13K	97.2K	1.14M	-1.44M	438.02K
Change in Receivables	0	0	0	0	0
Change in Inventory	0	0	0	0	0
Change in Payables	60.13K	-25.85K	475.4K	-440.34K	332.28K
Cash from Investing+	0	0	-8.74K	0	0
Capital Expenditures	0	0	-8.74K	0	0
CapEx % of Revenue	-	-	0.87%	-	-
Acquisitions	-	-	-	-	-
Investments	-	-	-	-	-
Other Investing	0	0	0	0	0
Cash from Financing+	209.94K	387.4K	967.29K	8.57M	8.42M
Debt Issued (Net)	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-
Dividends Paid	0	0	0	0	0
Share Repurchases	-	-	-	-	-
Other Financing	25	100	0	1.49M	105.82K
Net Change in Cash	-	-	-	-	-
Free Cash Flow+	-211.71K	-382.4K	-919.63K	-6M	-5.61M
FCF Margin %	-	-	-91.96%	-92.33%	-
FCF Growth %	-	-0.81%	-1.4%	-5.53%	0.07%
FCF per Share	-0.04	-0.07	-0.15	-0.99	-0.68
FCF Conversion (FCF/Net Income)	0.62x	0.65x	0.33x	1.12x	0.80x
Interest Paid	0	0	0	93.92K	0
Taxes Paid	0	0	0	0	0

Key Ratios

Metric	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-	-206.61%	-185.12%
Gross Margin	-	-	92%	92%	-
Net Margin	-	-	-28024.87%	-8239.8%	-
Interest Coverage	-29.51x	-13.75x	-7.07x	-67.87x	-398.52x
FCF Conversion	0.62x	0.65x	0.33x	1.12x	0.80x
Revenue Growth	-	-	-	550%	-100%

Frequently Asked Questions

Growth & Financials

Bullfrog AI Holdings, Inc. Common Stock (BFRG) reported $0.1M in revenue for fiscal year 2024.

Bullfrog AI Holdings, Inc. Common Stock (BFRG) saw revenue decline by 100.0% over the past year.

Bullfrog AI Holdings, Inc. Common Stock (BFRG) reported a net loss of $6.7M for fiscal year 2024.

Dividend & Returns

Bullfrog AI Holdings, Inc. Common Stock (BFRG) has a return on equity (ROE) of -185.1%. Negative ROE indicates the company is unprofitable.

Bullfrog AI Holdings, Inc. Common Stock (BFRG) had negative free cash flow of $5.6M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener